Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLIMEPIRIDE\ROSIGLITAZONE Cause Ischaemia? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Ischaemia have been filed in association with GLIMEPIRIDE\ROSIGLITAZONE. This represents 0.7% of all adverse event reports for GLIMEPIRIDE\ROSIGLITAZONE.

5
Reports of Ischaemia with GLIMEPIRIDE\ROSIGLITAZONE
0.7%
of all GLIMEPIRIDE\ROSIGLITAZONE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Ischaemia From GLIMEPIRIDE\ROSIGLITAZONE?

Of the 5 reports, 2 (40.0%) required hospitalization.

Is Ischaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE\ROSIGLITAZONE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does GLIMEPIRIDE\ROSIGLITAZONE Cause?

Myocardial infarction (259) Cardiac failure congestive (225) Cerebrovascular accident (144) Coronary artery disease (111) Acute myocardial infarction (45) Coronary arterial stent insertion (34) Atrial fibrillation (22) Myocardial ischaemia (18) Chest pain (17) Coronary artery bypass (17)

What Other Drugs Cause Ischaemia?

ROSIGLITAZONE (217) TESTOSTERONE (142) TESTOSTERONE CYPIONATE (126) TESTOSTERONE ENANTHATE (122) AMLODIPINE (81) ADALIMUMAB (65) DABIGATRAN ETEXILATE (63) ASPIRIN (56) CARBOPLATIN (54) BEVACIZUMAB (50)

Which GLIMEPIRIDE\ROSIGLITAZONE Alternatives Have Lower Ischaemia Risk?

GLIMEPIRIDE\ROSIGLITAZONE vs GLIPIZIDE GLIMEPIRIDE\ROSIGLITAZONE vs GLIVEC GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB-GXBM GLIMEPIRIDE\ROSIGLITAZONE vs GLUCAGON

Related Pages

GLIMEPIRIDE\ROSIGLITAZONE Full Profile All Ischaemia Reports All Drugs Causing Ischaemia GLIMEPIRIDE\ROSIGLITAZONE Demographics